Background:
- While estrogen receptor (ER) is well-studied in breast cancer (BC), the role of androgen receptor (AR) in prognosis and therapy response is less understood.
- Here, we aimed to characterize the clinicopathologic and molecular features of AR gene expression in BC subtypes.